Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Reference113 articles.
1. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
2. Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors
3. Pancreatic neuroendocrine tumors: A population-based analysis of epidemiology and outcomes.
4. ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical Intricacies and Advances in Neuroendocrine Tumors: An Organ-Based Multidisciplinary Approach;Journal of Computer Assisted Tomography;2024-04-15
2. Responses to Medical Treatment in 192 Patients with Pancreatic Neuroendocrine Neoplasms Referred to the Copenhagen Neuroendocrine Tumour Centre in 2000–2020;Cancers;2024-03-18
3. Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) – Current literature review of diagnostics and therapy. What has changed in the management?;Polish Journal of Surgery;2024-03-08
4. Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis;World Journal of Gastroenterology;2024-02-21
5. Resistant gastroenteropancreatic neuroendocrine tumors: a definition and guideline to medical and surgical management;Baylor University Medical Center Proceedings;2023-12-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3